Advertisement
News| Volume 12, ISSUE 3, P425-428, 2010

Developments in clinical cell therapy

DOI:https://doi.org/10.3109/14653240903511952
Developments in clinical cell therapy
Previous ArticleLarge-scale Ficoll gradient separations using a commercially available, effectively closed, system
Next ArticleReplenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa

      Abstract

      Immunotherapy has become an important part of hematopoietic stem cell (HSC) transplantation and cancer therapy. Regenerative and reparative properties of somatic cell-based therapies hold tremendous promise for repairing injured tissue, preventing and reversing damage to organs, and restoring balance to compromised immune systems. The principles and practices of the diverse aspects of immune therapy for cancer, HSC transplantation and regenerative medicine have many commonalities. This meeting report summarizes a workshop sponsored by the National Heart, Lung and Blood Institute (NHLBI) and Production Assistance for Cellular Therapies (PACT), held on 23–24 April 2009 at the National Institutes of Health (NIH, USA). A series of scientific sessions and speakers highlighted key aspects of the latest scientific, clinical and technologic developments in cell therapy, involving a unique set of cell products with a special emphasis on converging concepts in these fields.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Suhoski M.M.
        • Golovina T.N.
        • Aqui N.A.
        • Tai V.C.
        • Varela-Rohena A.
        • Milone M.C.
        • et al.
        Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules.
        Mol. Ther. 2007; 15: 981-988
        View in Article
        • Le Blanc K.
        • Frassoni F.
        • Ball L.
        • Locatelli F.
        • Roelofs H.
        • Lewis I.
        • et al.
        Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.
        Developmental Committee of the European Group for Blood and Marrow Transplantation. Lancet. 2008; 371: 1579-1586
        View in Article
        • Le Blanc K.
        • Samuelsson H.
        • Gustafsson B.
        • Remberger M.
        • Sundberg B.
        • Arvidson J.
        • et al.
        Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells.
        Leukemia. 2007; 21: 1733-1738
        View in Article
        • Yee C.
        • Thompson J.A.
        • Byrd D.
        • Riddell S.R.
        • Roche P.
        • Celis E.
        • Greenberg P.D.
        Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with meta-static melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.
        Proc Natl Acad Sci USA. 2002; 99: 16168-16173
        View in Article
        • Bollard C.M.
        • Gottschalk S.
        • Leen A.M.
        • Weiss H.
        • Straathof K.C.
        • Carrum G.
        • et al.
        Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.
        Blood. 2007; 110: 2838-2845
        View in Article
        • DiGiusto D.L.
        • Cooper L.J.N.
        Preparing clinical-grade antigen-specific T cells for adoptive immunotherapy trials.
        Cytotherapy. 2007; 9: 613-629
        View in Article
        • Rosenberg S.A.
        • Restifo N.P.
        • Yang J.C.
        • Morgan R.A.
        • Dudley M.E.
        Adoptive cell transfer: a clinical path to effective cancer immunotherapy.
        Nat Rev Cancer. 2008; 8: 299-308
        View in Article
        • Levine B.L.
        • Humeau L.M.
        • Boyer J.
        • MacGregor R.R.
        • Rebello T.
        • Lu X.
        • et al.
        Gene transfer in humans using a conditionally replicating lentiviral vector.
        Proc Natl Acad Sci USA. 2006; 103: 17372-17377
        View in Article
        • Cooley S.
        • Gada P.
        • McKenna D.
        • McCullar V.
        • Fautsch S.
        • Verneris M.
        • et al.
        Successful haploidentical hematopoietic cell engraftment using a non-myeloablative preparative regimen including natural killer (NK) cells.
        50th ASH Annual Meeting Abstracts. Blood. 2008; 112: 307
        View in Article
        • Berg M.
        • Lundqvist A.
        • McCoy P.
        • Leigh S.
        • Fan Y.
        • Tawab A.
        • Childs R.
        Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells.
        Cytotherapy. 2009; 11: 341-355
        View in Article
        • Mailliard R.B.
        • Wankowicz-Kalinska A.
        • Cai Q.
        • Wesa A.
        • Hilkens C.M.
        • Kapsenberg M.L.
        • et al.
        Alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity.
        Cancer Res. 2004; 64: 5934-5937
        View in Article
        • Whiteside T.L.
        • Piazza P.
        • Reiter A.
        • Stanson J.
        • Connolly N.C.
        • Rinaldo R.R.
        • et al.
        Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection.
        Clin. Vaccine Immunol. 2009; 16: 233-240
        View in Article
        • Love Z.
        • Wang F.
        • Dennis J.
        • Awadallah A.
        • Salem N.
        • Lin Y.
        • et al.
        Imaging of mesenchymal stem cell transplant by bioluminescence and PET.
        J Nucl Med. 2007; 48: 2011-2020
        View in Article
        • Ahrens E.T.
        • Flores R.
        • Xu H.
        • Morel P.A.
        In vivo imaging platform for tracking immunotherapeutic cells.
        Nat. Biotechnol. 2005; 23: 983-987
        View in Article
        • O’Gorman W.E.
        • Dooms H.
        • Thorne S.H.
        • Kuswanto W.F.
        • Simonds E.F.
        • Krutzik P.O.
        • et al.
        The initial phase of an immune response functions to activate regulatory T cells.
        J Immunol. 2009; 183: 332-339
        View in Article
        • Krutzik P.O.
        • Nolan G.P.
        Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events.
        Cytometry. 2003; 55: 61-70
        View in Article

      Article info

      Publication history

      Accepted: November 25, 2009
      Received: October 22, 2009

      Identification

      DOI: https://doi.org/10.3109/14653240903511952

      Copyright

      © 2010 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX